ZYMFENTRA
NDC 72606-047, infliximab-dyyb, injection, from CELLTRION USA Inc..
- Product NDC
- 72606-047
- Status
- Listed
- Labeler
- CELLTRION USA Inc.
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761358
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72606-047 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INFLIXIMAB-DYYB120 mg/mL
Pharmacologic classes
Tumor Necrosis Factor Blocker [EPC]; Tumor Necrosis Factor Receptor Blocking Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72606-047-01 | 72606004701 | 1 SYRINGE in 1 CARTON (72606-047-01) / 1 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/93a193ab-9f96-4da6-aa7c-31212e81879a
Use it
Look up 72606-047 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72606-047 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72606-047. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.